AIMT - Aimmune Therapeutics Inc. (AIMT) CEO Jayson Dallas on Q4 2019 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q4 2019 Results Earnings Conference Call
February 27, 2020, 04:30 PM ET
Company Participants
DeDe Sheel - Vice President of Investor Relations
Eric Bjerkholt - Chief Financial Officer
Jayson Dallas - President and Chief Executive Officer
Andrew Oxtoby - Chief Commercial Officer
Conference Call Participants
Chris Raymond - Piper Sandler
Charles Duncan - Cantor Fitzgerald
Liana Moussatos - Wedbush Securities
Evan Seigerman - Credit Suisse.
Zegbeh Jallah - Roth Capital Partners
Corinne Jenkins - with Goldman Sach
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the